United States Antimony (UAMY) Common Equity (2010 - 2026)

United States Antimony has reported Common Equity for 15 years, with the latest figure at $141.0 million in Q4 2025.

• Quarterly Common Equity rose 392.84% year-over-year to $141.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $141.0 million (up 392.84% YoY) and the FY2025 annual result came in at $141.0 million, up 392.84% from the prior year.
• Common Equity rose to $141.0 million in Q4 2025 per UAMY's latest filing, from $71.8 million in the prior quarter.
• Over five years, Common Equity peaked at $141.0 million in Q4 2025 and troughed at $25.1 million in Q3 2024.
• A 5-year average of $38.3 million and a median of $32.1 million in 2021 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2025: Common Equity declined 19.92% in 2023, then soared 392.84% in 2025.
• Over 5 years, Common Equity stood at $32.4 million in 2021, then retreated by 1.54% to $31.9 million in 2022, then dropped by 19.92% to $25.5 million in 2023, then grew by 12.07% to $28.6 million in 2024, then jumped by 392.84% to $141.0 million in 2025.
• According to Business Quant data, Common Equity over the past three periods registered $141.0 million, $71.8 million, and $37.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.